Medicines now the top hi-tech Australian export in 2009

4 January 2010

Australia's pharmaceutical industry has overtaken road vehicles to become the nation's largest hi-tech exporter, according to a new industry 'Facts Book,' which contains key industry statistics and other information. It highlights the contribution of the local pharmaceutical industry to the health and economic wellbeing of Australians.

Brendan Shaw, acting chief executive of the research-based drugmakers group Medicines Australia, said the information, compiled by his association, demonstrates the value of Australia's new largest hi-tech exporter.

'Australians can be very proud that fellow-Aussies have been working relentlessly at the lab bench, in hospitals and factories and in many other environments to bring new medicines and vaccines to patients both in Australia and overseas,' Dr Shaw said, adding: 'This is a real export success story. Every day, these new medicines are saving, improving and extending lives of ordinary Australians and patients in other countries.'

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical